TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
SOLV

Solventum Corp.

Healthcare · Medical Instruments & Supplies

88.80$ -0.1% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Income Statement

Solventum Corp. (SOLV) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 8,325 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement SOLV
Line item 2020 2021 2022 2023 2024 2025
7,281 8,171 8,130 8,197 8,254 8,325
2,966 3,248 3,435 3,504 3,661 3,874
4,315 4,923 4,695 4,693 4,593 4,451
719 766 767 758 775 739
2,166 2,278 2,235 2,321 2,782 3,080
2,885 3,044 3,002 3,001 3,557 2,270
1,430 1,879 1,693 1,692 1,036 2,181
0.0 0.0 367 347
1,440 1,882 1,692 1,667 605 1,713
302 422 349 321 127 157
1,138 1,460 1,343 1,346 479 1,556
2,029 2,479 2,270 2,228 1,527 2,549

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?